Loading...
•
Dec 31, 2024
HCA Q4 2024 Earnings Report
HCA Healthcare's Q4 2024 results were announced, demonstrating strong business fundamentals and operational improvements.
Key Takeaways
HCA Healthcare reported revenues of $18.285 billion and net income of $1.438 billion for the fourth quarter of 2024. The company's performance was driven by increased admissions and equivalent admissions, reflecting continued growth and operational efficiency.
Revenues reached $18.285 billion.
Net income attributable to HCA Healthcare, Inc. was $1.438 billion, or $5.63 per diluted share, impacted by Hurricanes Helene and Milton.
Adjusted EBITDA totaled $3.712 billion.
Cash flows from operating activities amounted to $2.559 billion.
HCA
HCA
Forward Guidance
HCA Healthcare issued its financial guidance for 2025, projecting revenues between $72.80 and $75.80 billion and net income attributable to HCA Healthcare, Inc. between $5.85 and $6.29 billion.
Positive Outlook
- Revenues are projected to be between $72.80 and $75.80 billion.
- Net Income Attributable to HCA Healthcare, Inc. is expected to be between $5.85 and $6.29 billion.
- Adjusted EBITDA is forecasted to be between $14.30 and $15.10 billion.
- EPS (diluted) is projected to be between $24.05 and $25.85 per diluted share.
- Capital expenditures for 2025 are estimated to be approximately $5.0 to $5.2 billion.
Challenges Ahead
- Guidance is subject to uncertainties and risks.
- Potential impacts from volume growth and operating environment.
- Consideration of payer mix and health care policy developments.
- General economic conditions, including inflation, are a factor.
- Exclusion of unpredictable items like gains/losses on sales of facilities.